You'll hear more controversy about ezetimibe (Ezetrol)

December 2009

You'll hear more controversy about ezetimibe (Ezetrol).

The latest data suggest that ezetimibe doesn't reduce atherosclerosis as well as niacin...when these are added to a statin.

Ezetimibe lowers LDL better than niacin...and the current thinking is "lower is better."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Vaccines too much pandemic H1N1 flu - very little testing for flu strain - too little vaccine - but enough Tamiflu
more options for patients who need LIQUID Tamiflu
Diabetes Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes
Osteoporosis how long women should take a bisphosphonate for osteoporosis
Infectious Diseases Canadian cystic fibrosis patients will now be able to get Cayston (aztreonam)
Infectious Diseases Doribax (doripenem) is now the fourth carbapenem
HIV & AIDS hypersensitivity and serious skin reactions associated with Intelence (etravirine)
Women's Health whether nitrofurantoin and TMP/SMX are safe to use during pregnancy
Cardiology start beta-blockers earlier before surgery
Interactions It's okay to give IV calcium and ceftriaxone immediately after one another in most patients
Dermatology how to choose a topical corticosteroid for skin problems
Hypertension new emphasis on treating hypertension in KIDS
Dyslipidemia You'll hear more controversy about ezetimibe (Ezetrol)